These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 16239501)
1. Role of lymphotoxin in experimental models of infectious diseases: potential benefits and risks of a therapeutic inhibition of the lymphotoxin-beta receptor pathway. Spahn TW; Eugster HP; Fontana A; Domschke W; Kucharzik T Infect Immun; 2005 Nov; 73(11):7077-88. PubMed ID: 16239501 [No Abstract] [Full Text] [Related]
2. A role for the lymphotoxin/LIGHT axis in the pathogenesis of murine collagen-induced arthritis. Fava RA; Notidis E; Hunt J; Szanya V; Ratcliffe N; Ngam-Ek A; De Fougerolles AR; Sprague A; Browning JL J Immunol; 2003 Jul; 171(1):115-26. PubMed ID: 12816989 [TBL] [Abstract][Full Text] [Related]
3. Differential activities of secreted lymphotoxin-alpha3 and membrane lymphotoxin-alpha1beta2 in lymphotoxin-induced inflammation: critical role of TNF receptor 1 signaling. Sacca R; Cuff CA; Lesslauer W; Ruddle NH J Immunol; 1998 Jan; 160(1):485-91. PubMed ID: 9552007 [TBL] [Abstract][Full Text] [Related]
4. A lymphotoxin-IFN-beta axis essential for lymphocyte survival revealed during cytomegalovirus infection. Banks TA; Rickert S; Benedict CA; Ma L; Ko M; Meier J; Ha W; Schneider K; Granger SW; Turovskaya O; Elewaut D; Otero D; French AR; Henry SC; Hamilton JD; Scheu S; Pfeffer K; Ware CF J Immunol; 2005 Jun; 174(11):7217-25. PubMed ID: 15905567 [TBL] [Abstract][Full Text] [Related]
5. Membrane lymphotoxin is required for resistance to Theiler's virus infection. Lin X; Ma X; Rodriguez M; Feng X; Zoecklein L; Fu YX; Roos RP Int Immunol; 2003 Aug; 15(8):955-62. PubMed ID: 12882833 [TBL] [Abstract][Full Text] [Related]
8. Lymphotoxin and LIGHT signaling pathways and target genes. Schneider K; Potter KG; Ware CF Immunol Rev; 2004 Dec; 202():49-66. PubMed ID: 15546385 [TBL] [Abstract][Full Text] [Related]
9. Activation of the lymphotoxin beta receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells. Degli-Esposti MA; Davis-Smith T; Din WS; Smolak PJ; Goodwin RG; Smith CA J Immunol; 1997 Feb; 158(4):1756-62. PubMed ID: 9029113 [TBL] [Abstract][Full Text] [Related]
10. Selective disruption of lymphotoxin ligands reveals a novel set of mucosal lymph nodes and unique effects on lymph node cellular organization. Rennert PD; Browning JL; Hochman PS Int Immunol; 1997 Nov; 9(11):1627-39. PubMed ID: 9418124 [TBL] [Abstract][Full Text] [Related]
11. Lymphotoxin alpha 1 beta 2: a critical mediator in V alpha 14i NKT cell differentiation. Franki AS; Van Beneden K; Dewint P; Meeus I; Veys E; Deforce D; Elewaut D Mol Immunol; 2005 Feb; 42(4):413-7. PubMed ID: 15607792 [TBL] [Abstract][Full Text] [Related]
12. Neither lymphotoxin alpha nor lymphotoxin beta receptor expression is required for biogenesis of lymphoid aggregates or differentiation of natural killer cells in the pregnant mouse uterus. Kather A; Chantakru S; He H; Minhas K; Foster R; Markert UR; Pfeffer K; Croy BA Immunology; 2003 Mar; 108(3):338-45. PubMed ID: 12603600 [TBL] [Abstract][Full Text] [Related]
13. Intestinal cryptopatch formation in mice requires lymphotoxin alpha and the lymphotoxin beta receptor. Taylor RT; Lügering A; Newell KA; Williams IR J Immunol; 2004 Dec; 173(12):7183-9. PubMed ID: 15585839 [TBL] [Abstract][Full Text] [Related]
14. [Tumor necrosis factor alpha and beta (TNF-alpha and -beta) in pathogenesis of rheumatoid arthritis]. Yamamura M Nihon Rinsho; 2005 Jan; 63 Suppl 1():145-52. PubMed ID: 15799335 [No Abstract] [Full Text] [Related]
15. Morphogenic and host protective functions executed by tumor necrosis factor receptors, lymphotoxin receptors and their ligands. Pfeffer K Eur Cytokine Netw; 2000 Sep; 11(3):514. PubMed ID: 11203200 [No Abstract] [Full Text] [Related]
16. Postgestational lymphotoxin/lymphotoxin beta receptor interactions are essential for the presence of intestinal B lymphocytes. Newberry RD; McDonough JS; McDonald KG; Lorenz RG J Immunol; 2002 May; 168(10):4988-97. PubMed ID: 11994450 [TBL] [Abstract][Full Text] [Related]
17. Lymphotoxin beta receptor-Ig fusion protein treatment blocks actively induced, but not adoptively transferred, uveitis in Lewis rats. Shao H; Fu Y; Song L; Sun S; Kaplan HJ; Sun D Eur J Immunol; 2003 Jun; 33(6):1736-43. PubMed ID: 12778492 [TBL] [Abstract][Full Text] [Related]
18. Expression of an adenovirally encoded lymphotoxin-beta inhibitor prevents clearance of Listeria monocytogenes in mice. Trüeb R; Brown G; Van Huffel C; Poltorak A; Valdez-Silva M; Beutler B J Inflamm; 1995; 45(4):239-47. PubMed ID: 8867668 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system. Warzocha K; Bienvenu J; Coiffier B; Salles G Eur Cytokine Netw; 1995; 6(2):83-96. PubMed ID: 7578992 [TBL] [Abstract][Full Text] [Related]
20. Blockade of lymphotoxin signaling inhibits the clinical expression of murine graft-versus-host skin disease. Wu Q; Fu YX; Sontheimer RD J Immunol; 2004 Feb; 172(3):1630-6. PubMed ID: 14734744 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]